Keyphrases
% Protection
7%
Acetone Extraction
47%
Analgesic
7%
Ankyrin
9%
Astringin
9%
Average Yields
9%
Bacteriome
9%
C-C Chemokine Receptor Type 5 (CCR5)
47%
C-X-C Chemokine Receptor Type 4 (CXCR4)
34%
Ca2+ Influx
9%
Calcium Assay
7%
CCR5 Receptor
95%
Chemically Induced
9%
Co-receptor
20%
CXCR4 Receptor
95%
Desensitization
7%
Drug Toxicity
7%
Drying Process
9%
HIV-1 Inhibition
95%
Imaging Plate
7%
Improved Extraction
9%
Inflammatory Pain
7%
Intestinal Immunity
9%
Intestinal Inflammation
19%
Irritant
9%
Isorhapontin
9%
Ligand-based Virtual Screening
47%
Pharmaceutical Science
47%
Pharmacogenetic Testing
95%
Photolabile
7%
Photoprotection
7%
Photostability
47%
Polyphenolic Compounds
7%
Process Extraction
9%
Recovery Percentage
7%
Regret
47%
Screening Approach
100%
Simple Steps
9%
Structure-based Virtual Screening
47%
Time Extraction
9%
Transient Receptor Potential Vanilloid 1 (TRPV1)
19%
Transient Receptor Potential Vanilloid 4 (TRPV4)
52%
TRP Channels
7%
TRPA1 Antagonists
7%
TRPA1 Channel
23%
TRPA1 Ion Channel
47%
TRPV4 Antagonist
47%
TRPV4 Channels
47%
Yield Extraction
9%
Yield Line
47%
Pharmacology, Toxicology and Pharmaceutical Science
Aglycone
19%
Ankyrin
23%
Antiinflammatory Activity
6%
Antioxidant
6%
Chemokine Receptor
11%
Chemokine Receptor CCR5
95%
Chemokine Receptor CXCR4
95%
Chemokine Receptor CXCR4 Antagonist
11%
Chronic Cough
9%
Cytotoxicity
6%
Desensitization
11%
Disease
9%
Drosophila
7%
Drug Carrier
47%
Enteritis
15%
Fruit Fly
9%
Glutamic Acid Derivative
11%
Headache
9%
Human Immunodeficiency Virus Fusion Inhibitor
95%
Inflammatory Pain
11%
Irritant Agent
7%
Mesoporous Silica Nanoparticle
6%
Nanocarrier
13%
Nanoparticle
47%
Natural Product
6%
Norway Spruce
47%
Pharmaceutics
47%
Pharmacological Activity
9%
Pinosylvin
79%
Polyethyleneimine
6%
Polyphenol
9%
Polyphenol Derivative
11%
Porous Silicon
6%
Receptor
47%
Scots Pine
47%
Sodium Chloride
11%
Spruce
9%
Stilbene
47%
Stilbene Derivative
19%
Transient Receptor Potential Channel
9%
Transient Receptor Potential Channel A1
47%
Ultraviolet Radiation
6%
Vanilloid Receptor 4
15%
Virtual Screening
47%